5-Amino-2-fluorobenzoic acid | CAS:56741-33-4

We serve 5-Amino-2-fluorobenzoic acid CAS:56741-33-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Amino-2-fluorobenzoic acid

Chemical Name:5-Amino-2-fluorobenzoic acid
CAS.NO:56741-33-4
Synonyms:5-amino-2-fluorobenzoic acid;
Molecular Formula:C7H6FNO2
Molecular Weight:155.12600
 
Physical and Chemical Properties:
Density:1.43;
Melting point:190oC;
Boiling point:351.3oC;
Flash point:166.3oC;
Index of Refraction:1.606;
 
Specification:
Appearance:Dark cream or beige powder 
Purity(HPLC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 5-Amino-2-fluorobenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-amino-2-fluorobenzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Amino-2-fluorobenzoic acid Use and application,5-Amino-2-fluorobenzoic acid technical grade,usp/ep/jp grade.


Related News: But several border points remain open, and many medical workers fear that Hong Kong’s well-regarded health care system will be overwhelmed.2-(Hydroxymethyl)pyridine manufacturer Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.Tetrachloropropene supplier Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.Calcium beta-hydroxy-beta-methylbutyrate vendor Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.“We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”